Taken together, these gene expression data suggest that the expressions of AATs (SLC7A5/LAT1, SLC38A2, and SLC1A5) are elevated in KRAS mutant CRC patient tissues and mouse intestinal organoids expressing the endogenous KRAS mutation. This evidence concerns the gene KRAS and colorectal carcinoma.